| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,792 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,045 |
| 424/277.1 |
Cancer cell or component thereof |
384 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
968 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6709658 |
Pneumococcal vaccines formulated with interleukin-12 |
Mar. 23, 2004 |
| 6709659 |
Antibodies that bind testis-specific insulin homolog polypeptides |
Mar. 23, 2004 |
| 6709661 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Mar. 23, 2004 |
| 6709672 |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction |
Mar. 23, 2004 |
| 6709829 |
Methods and compositions for detection of disease |
Mar. 23, 2004 |
| 6710035 |
Generation of an immune response to a pathogen |
Mar. 23, 2004 |
| 6706266 |
Oncostatin M antagonists |
Mar. 16, 2004 |
| 6706269 |
Moraxella catarrhalis PILQ proteins |
Mar. 16, 2004 |
| 6706270 |
Compounds |
Mar. 16, 2004 |
| 6706271 |
Cloning of BASB023 antigen from Moraxella catarrhalis |
Mar. 16, 2004 |
| 6706486 |
Method for the quantitative release of natural or recombinant proteins, polypeptides or peptides |
Mar. 16, 2004 |
| 6706494 |
BASB028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
Mar. 16, 2004 |
| 6706523 |
Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
Mar. 16, 2004 |
| 6706694 |
Expression of exogenous polynucleotide sequences in a vertebrate |
Mar. 16, 2004 |
| 6703025 |
Multicomponent vaccines |
Mar. 9, 2004 |
| 6703231 |
gM-negative EHV-mutants |
Mar. 9, 2004 |
| 6703238 |
Methods for expanding antigen-specific T cells |
Mar. 9, 2004 |
| 6703362 |
Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
Mar. 9, 2004 |
| 6699656 |
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
Mar. 2, 2004 |
| 6699673 |
Protein methylarginine-specific antibodies |
Mar. 2, 2004 |
| 6699678 |
Chlamydia trachomatis specific peptides and their use in diagnostic assays |
Mar. 2, 2004 |
| 6699467 |
Compounds and compositions for delivering active agents |
Mar. 2, 2004 |
| 6696065 |
Acellular pertussis vaccines and methods of preparation thereof |
Feb. 24, 2004 |
| 6696421 |
DNA immunization against chlamydia infection |
Feb. 24, 2004 |
| 6692745 |
Compositions and methods for inhibition of HIV-1 infection |
Feb. 17, 2004 |
| 6692746 |
Tumor killing effects of enterotoxins, superantigens, and related compounds |
Feb. 17, 2004 |
| 6692747 |
Alloferons--immunomodulatory peptides |
Feb. 17, 2004 |
| 6692750 |
Alphavirus expression vector |
Feb. 17, 2004 |
| 6693175 |
Method for diagnosing bone dysbolism |
Feb. 17, 2004 |
| 6693186 |
Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
Feb. 17, 2004 |
| 6689354 |
Immunogenic preparation and method for improving the productivity of ruminant animals |
Feb. 10, 2004 |
| 6689355 |
Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
Feb. 10, 2004 |
| 6689360 |
Human B-cell translocation genes-2 and 3 antibodies |
Feb. 10, 2004 |
| 6689364 |
Borrelia burgdorferi polypeptides and uses thereof |
Feb. 10, 2004 |
| 6689369 |
Immunogenic pneumococcal protein and vaccine compositions thereof |
Feb. 10, 2004 |
| 6689753 |
.beta. sheet breaker peptide analogs that inhibit .beta. pleated sheet formation in amyloid .beta.-peptide |
Feb. 10, 2004 |
| 6685911 |
Sensitization process for antigen-presenting cells and means for implementing the process |
Feb. 3, 2004 |
| 6685943 |
Fibronectin binding protein compositions and methods of use |
Feb. 3, 2004 |
| 6685949 |
Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans |
Feb. 3, 2004 |
| 6686166 |
Molecular differences between species of the M. tuberculosis complex |
Feb. 3, 2004 |
| 6686447 |
Compositions and methods for the therapy and diagnosis of lung cancer |
Feb. 3, 2004 |
| 6682729 |
Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
Jan. 27, 2004 |
| 6682739 |
Methods of inhibiting osteoclastogenesis |
Jan. 27, 2004 |
| 6682741 |
.beta.2 microglobulin fusion proteins and high affinity variants |
Jan. 27, 2004 |
| 6682744 |
Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
Jan. 27, 2004 |
| 6682746 |
Adjuvanted vaccine which is substantially free of non-host albumin |
Jan. 27, 2004 |
| 6682754 |
Ovo delivery of an immunogen containing implant |
Jan. 27, 2004 |
| 6683052 |
Lipopeptides containing an interferon-.gamma. fragment, and uses thereof in pharmaceutical compositions |
Jan. 27, 2004 |
| 6680055 |
Mycolactone and related compounds, compositions and methods of use |
Jan. 20, 2004 |
| 6680058 |
Compositions and methods for contraception in or sterilization of mammals |
Jan. 20, 2004 |
|
|
|
